Theravance Biopharma, Inc. (NASDAQ:TBPH) Q2 2023 Earnings Call Transcript August 7, 2023 Operator: Ladies and gentlemen, good afternoon. I’d like to welcome everyone to Theravance Biopharma’s Second Quarter 2023 Conference Call. During the presentation, all participants will be in a listen-only mode. A question-and-answer session will follow the company’s formal remarks. [Operator Instructions] Also, today’s […]